| 000 | 01832 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516020608.0 | ||
| 264 | 0 | _c20110606 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2010-10-306571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOh, Unsong | |
| 245 | 0 | 0 |
_aInhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. _h[electronic resource] |
| 260 |
_bBlood _cMar 2011 |
||
| 300 |
_a3363-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclohexanones _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHuman T-lymphotropic virus 1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aParaparesis, Tropical Spastic _xblood |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 700 | 1 | _aMcCormick, Matthew J | |
| 700 | 1 | _aDatta, Dibyadeep | |
| 700 | 1 | _aTurner, Richard V | |
| 700 | 1 | _aBobb, Kathryn | |
| 700 | 1 | _aMonie, Dileep D | |
| 700 | 1 | _aSliskovic, D Robert | |
| 700 | 1 | _aTanaka, Yuetsu | |
| 700 | 1 | _aZhang, Jie | |
| 700 | 1 | _aMeshulam, Jeffrey | |
| 700 | 1 | _aJacobson, Steven | |
| 773 | 0 |
_tBlood _gvol. 117 _gno. 12 _gp. 3363-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2010-10-306571 _zAvailable from publisher's website |
| 999 |
_c20497441 _d20497441 |
||